Skip Navigation LinksHome > Research > AABB Hemovigilance > Biovigilance

Skip Navigation LinksHome > Research > AABB Hemovigilance > Biovigilance

 

Initiated in 2006, the U.S. Biovigilance Network is a unique public-private collaboration between the U.S. Department of Health and Human Services, including the Centers for Disease Control and Prevention, and organizations involved in blood collection, transfusion, tissue and organ transplantation, and cellular therapies. The goal of the network is to enhance patient safety and protect donor health while also reducing overall health care-related costs.

This section includes information on the system components; background on the development of the network; a list of organizations currently contributing data; a list of companies, organizations and individuals that have invested financially in the network; testimonials from those who have had experience with various systems; related news coverage; and contact information for those interested in learning more about how they can get involved.